Ubs Asset Management Americas Inc Oric Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 35,579 shares of ORIC stock, worth $278,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,579
Previous 23,034
54.46%
Holding current value
$278,939
Previous $236,000
21.61%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ORIC
# of Institutions
132Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$41.4 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$37.9 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$34.7 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$34.5 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$30.6 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $310M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...